Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Distant monitoring earlier than and after surgical procedure has been discovered by researchers to be related to improved restoration for sufferers with...
The U.S. Meals and Drug Administration (FDA) has permitted Zepzelca (lurbinectedin) together with Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for...
As September concludes, the panorama of hematologic oncology continues to evolve, spanning the total spectrum of blood most cancers care. Latest scientific...
